JERUSALEM, ISRAEL / ACCESSWIRE / June 14, 2018 / IDenta Corp (OTC PINK: IDTA), a worldwide leader in the development of Drug, Drug Precursor and Explosive Detection Field Kits, will hold its annual meeting on June 27, 2018, at 8:30 pm at the Company's headquarters at 120 Bethlehem Road, Jerusalem 9342001, Israel. Amichai Glattstein, CEO of IDenta Corp said, "We are excited about the annual meeting, and we look forward to seeing all the attendees. We will update the company's current status as well as our future plans."
About IDenta Corp.
Since 2002, IDenta Corporation and its subsidiary IDenta Ltd has been recognized as a worldwide leader in the development of proprietary on-site Drug, Drug Precursor and Explosive Detection kits. IDenta Corp. develops, manufactures and distributes revolutionary products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.
Safe Harbor Statement
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
Company Contact Information:
SOURCE: IDenta Corp.